ME03429B - Kationski polimeri na bazi glikogena - Google Patents

Kationski polimeri na bazi glikogena

Info

Publication number
ME03429B
ME03429B MEP-2019-189A MEP2019189A ME03429B ME 03429 B ME03429 B ME 03429B ME P2019189 A MEP2019189 A ME P2019189A ME 03429 B ME03429 B ME 03429B
Authority
ME
Montenegro
Prior art keywords
glycogen
cationic polymers
based cationic
polymers
cationic
Prior art date
Application number
MEP-2019-189A
Other languages
German (de)
English (en)
French (fr)
Inventor
Vincenzo Russo
Elisa Liberati
Nicola Cazzolla
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of ME03429B publication Critical patent/ME03429B/me

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/18—Reserve carbohydrates, e.g. glycogen, inulin, laminarin; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
MEP-2019-189A 2012-03-15 2013-02-21 Kationski polimeri na bazi glikogena ME03429B (me)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12159710 2012-03-15
EP13704973.0A EP2825565B1 (en) 2012-03-15 2013-02-21 Glycogen-based cationic polymers
PCT/EP2013/053422 WO2013135471A1 (en) 2012-03-15 2013-02-21 Glycogen-based cationic polymers

Publications (1)

Publication Number Publication Date
ME03429B true ME03429B (me) 2020-01-20

Family

ID=47739282

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2019-189A ME03429B (me) 2012-03-15 2013-02-21 Kationski polimeri na bazi glikogena

Country Status (29)

Country Link
US (1) US9717801B2 (me)
EP (1) EP2825565B1 (me)
JP (1) JP6247234B2 (me)
KR (1) KR101997018B1 (me)
CN (2) CN104080812B (me)
AR (1) AR090307A1 (me)
AU (1) AU2013231561B2 (me)
BR (1) BR112014018617A8 (me)
CA (1) CA2859273C (me)
CY (1) CY1121829T1 (me)
DK (1) DK2825565T3 (me)
EA (1) EA032479B1 (me)
ES (1) ES2732216T3 (me)
GE (1) GEP201606581B (me)
HR (1) HRP20191114T1 (me)
HU (1) HUE045049T2 (me)
IL (1) IL233823B (me)
LT (1) LT2825565T (me)
ME (1) ME03429B (me)
MX (1) MX351599B (me)
PL (1) PL2825565T3 (me)
PT (1) PT2825565T (me)
RS (1) RS58985B1 (me)
SG (2) SG10201607577QA (me)
SI (1) SI2825565T1 (me)
SM (1) SMT201900342T1 (me)
TR (1) TR201909387T4 (me)
UA (1) UA115135C2 (me)
WO (1) WO2013135471A1 (me)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR095937A1 (es) 2013-04-05 2015-11-25 Acraf Potenciador de la solubilidad en agua a base de glucógeno
EP2988725A4 (en) 2013-04-26 2016-03-09 Mirexus Biotechnologies Inc MONOPERATED GLYCOGEN AND PHYTOGLYCOGEN NANOTEHICLES AND USE THEREOF AS ADDITIVES IN COSMETIC PREPARATIONS, MEDICAMENTS AND FOOD PRODUCTS
HK1244030A1 (en) * 2014-12-29 2018-07-27 东丽株式会社 Composition containing nucleic acid molecule stably
CN104558246B (zh) * 2015-01-20 2017-03-01 武汉理工大学 一种叶酸/生物素修饰的壳聚糖材料及其制备方法
DE102015205088C5 (de) * 2015-03-20 2024-09-26 Kuka Deutschland Gmbh Verfahren zum Ermitteln eines Kalibrierungsparameters eines Fahrzeuges sowie Fahrzeug hierzu
JP6872782B2 (ja) * 2016-03-08 2021-05-19 国立大学法人京都大学 カチオン性グルカンナノスフェア、複合体、核酸導入剤及びがん治療剤
JP2019513837A (ja) * 2016-04-14 2019-05-30 ミレクサス バイオテクノロジーズ インコーポレイテッド フィトグリコーゲンナノ粒子を含む抗感染症組成物
JP2019514963A (ja) * 2016-05-04 2019-06-06 ミレクサス バイオテクノロジーズ インコーポレイテッド 免疫抑制化合物および組成物としてのグリコーゲンおよびフィトグリコーゲンナノ粒子ならびにそれらの使用方法
CN105949344B (zh) * 2016-05-13 2019-05-17 中山大学 一种阳离子超支化多糖衍生物及其在增强血卟啉类光敏剂对肿瘤细胞光毒性方面的应用
WO2019027999A1 (en) * 2017-07-31 2019-02-07 Ohio State Innovation Foundation BIOMIMETIC NANOMATERIALS AND USES THEREOF
WO2019140304A1 (en) * 2018-01-11 2019-07-18 Virgina Tech Intellectual Properties Inc. Amphiphilic polysacchardides,polysaccharide-based hydrogels, and methods of manufacture
CN116178587B (zh) * 2023-02-28 2025-04-11 江南大学 一种季铵盐化糖原、复合抗菌水凝胶及其制备方法与应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8904370D0 (en) * 1989-02-25 1989-04-12 Cosmas Damian Ltd Liquid delivery compositions
IT1255488B (it) 1992-08-04 1995-11-06 Angelini Francesco Ist Ricerca Polisaccaridi del glicogeno
US7144713B1 (en) * 1995-10-02 2006-12-05 Emd Biosciences, Inc. Method for precipitating nucleic acid with visible carrier
GB9600272D0 (en) 1996-01-06 1996-03-06 Univ Nottingham Polymers
US6106858A (en) * 1997-09-08 2000-08-22 Skyepharma, Inc. Modulation of drug loading in multivescular liposomes
WO2002100435A1 (en) 2001-06-11 2002-12-19 Centre Hospitalier Universitaire De Montreal Compositions and methods for enhancing nucleic acid transfer into cells
US20030147958A1 (en) 2002-01-29 2003-08-07 Cheol-Hee Ahn Biodegradable multi-block copolymers of poly(amino acid)s and poly(ethylene glycol) for the delivery of bioactive agents
US20030186916A1 (en) 2002-03-12 2003-10-02 Lei Yu Vector for transfection of eukaryotic cells
US20090117657A1 (en) 2004-03-31 2009-05-07 Medgel Corporation Preparation For Transferring Nucleic Acid Into Cell
US8108158B2 (en) 2005-09-28 2012-01-31 Adrian H. Hetzel Electro-hydraulic timed angle controlled joint simulation torque calibration, certification and analysis device
UA97559C2 (uk) * 2007-11-08 2012-02-27 Оцука Фармасьютікал Ко., Лтд. Комплекс нуклеїнової кислоти і композиція для доставки нуклеїнової кислоти
CN101235098A (zh) * 2008-01-09 2008-08-06 浙江大学 功能性植物多糖的修饰方法
EP2366009B1 (en) * 2008-12-22 2012-10-24 Unilever PLC Laundry compositions
BRPI0923571A2 (pt) * 2008-12-22 2016-08-23 Unilever Nv composição detergente líquida, e, método para proporcionar maciez a um tecido
JP5649224B2 (ja) * 2009-05-08 2015-01-07 江崎グリコ株式会社 グルクロン酸含有グルカン、その製造法および利用
EP2275085A1 (en) * 2009-07-07 2011-01-19 University of Rostock Biodegradable copolymer suitable for delivering nucleic acid materials into cells
CN102068698A (zh) * 2009-11-24 2011-05-25 深圳先进技术研究院 纳米疫苗及其制备方法

Also Published As

Publication number Publication date
CN104080812A (zh) 2014-10-01
EA201491613A1 (ru) 2014-12-30
BR112014018617A2 (me) 2017-06-20
LT2825565T (lt) 2019-07-10
CN107236052B (zh) 2019-09-24
KR20150006414A (ko) 2015-01-16
AU2013231561A1 (en) 2014-07-10
CA2859273C (en) 2020-04-14
HK1203984A1 (en) 2015-11-06
SMT201900342T1 (it) 2019-07-11
WO2013135471A1 (en) 2013-09-19
HUE045049T2 (hu) 2019-12-30
CY1121829T1 (el) 2020-07-31
EP2825565A1 (en) 2015-01-21
CA2859273A1 (en) 2013-09-19
GEP201606581B (en) 2016-11-25
SI2825565T1 (sl) 2019-08-30
SG11201403816YA (en) 2014-08-28
EA032479B1 (ru) 2019-06-28
TR201909387T4 (tr) 2019-07-22
US20140378532A1 (en) 2014-12-25
MX351599B (es) 2017-10-20
ES2732216T3 (es) 2019-11-21
EP2825565B1 (en) 2019-04-03
PL2825565T3 (pl) 2019-10-31
US9717801B2 (en) 2017-08-01
HRP20191114T1 (hr) 2019-09-20
PT2825565T (pt) 2019-07-10
DK2825565T3 (da) 2019-06-24
AU2013231561B2 (en) 2017-06-08
KR101997018B1 (ko) 2019-07-05
CN104080812B (zh) 2017-06-27
AR090307A1 (es) 2014-11-05
UA115135C2 (uk) 2017-09-25
CN107236052A (zh) 2017-10-10
MX2014010698A (es) 2015-03-10
JP6247234B2 (ja) 2017-12-13
SG10201607577QA (en) 2016-11-29
RS58985B1 (sr) 2019-08-30
BR112014018617A8 (pt) 2017-07-11
JP2015510020A (ja) 2015-04-02
IL233823B (en) 2018-05-31
IL233823A0 (en) 2014-09-30

Similar Documents

Publication Publication Date Title
GB2515233B (en) Conjugated polymers
GB201201578D0 (en) Polymer
PL2877520T3 (pl) Polimery organopolisiloksanowe
IL236023A0 (en) Polymeric coatings
EP2921506A4 (en) MODIFIED POLYMER
GB201420620D0 (en) Conjugated Polymers
EP2934531A4 (en) COMBINATION
IL238985A0 (en) Thermotropic polymers
GB201420608D0 (en) Conjugated polymers
EP2925795A4 (en) PROPYLENE POLYMERS
GB2513034B (en) Polymer
IL233823A0 (en) Cationic polymers based on glycogen
GB201504715D0 (en) Conjugated polymers
SG11201502386PA (en) Polymerization process
ZA201408137B (en) Carbinol-terminated polymers containing amine
GB201411209D0 (en) Polymer
EP2911673A4 (en) COMBINATION
GB201219783D0 (en) Soluble polymers
ZA201409034B (en) Catalysts
GB201201357D0 (en) Poly oligosiloxysilane
GB201105482D0 (en) Polymers
PL2900733T3 (pl) Kopolimery z grupami gem-acetofosfonowymi
GB2500883B (en) Improved saw-horse
PL2746487T3 (pl) Profil kątowy
EP2925728A4 (en) COMBINATION